EMBRACE-STEMI: Drug targeting mitochondria does not reduce infarct size – Healio | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« TOTAL: Manual thrombectomy with PCI does not improve outcomes, increases … – Healio

Early invasive strategy benefits elderly patients with non-STEMI, unstable angina – Healio »

EMBRACE-STEMI: Drug targeting mitochondria does not reduce infarct size – Healio

April 21, 2015 by 2012pharmaceutical

EMBRACE-STEMI: Drug targeting mitochondria does not reduce infarct size – Healio

Reporter: Aviva Lev-Ari, PhD, RN

SAN DIEGO — The novel drug Bendavia did not meet any of its primary or secondary endpoints in a trial assessing its use prior to primary PCI in patients with STEMI, according to data presented at the American College of Cardiology Scientific Sessions.Patients…

Source: www.healio.com

See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Posted in Acute Myocardial Infarction, Frontiers in Cardiology and Cardiovascular Disorders, Myocardial Ischemia, Myocardial Metabolism | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 9,459 other subscribers
Recent Posts
- Creating a Twitter Space for @pharma_BI for Live Broadcasts March 14, 2023
- The Vibrant Philly Biotech Scene: Recent Happenings & Deals March 11, 2023
- Peak oxygen uptake (VO2peak) quantified fitness: Lifelong and late-onset athletes had higher VO2peak than non-athletes March 7, 2023
- Merck’s sotatercept overachieves, PCSK9 inhibitor passes phase 2 March 6, 2023
- Bacterial multidrug resistance problem solved by a broad-spectrum synthetic antibiotic March 1, 2023
- Genetic variation causes human lupus, systemic lupus erythematosus (SLE) February 23, 2023
- Mimicking vaginal cells and microbiome interactions on chip microfluidic culture February 14, 2023
- Press Release for Five Bilingual BioMed e-Series in English and in Spanish January 29, 2023
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: